Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Nov;83(22):8694–8698. doi: 10.1073/pnas.83.22.8694

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

R F Irie, D L Morton
PMCID: PMC386997  PMID: 3464977

Abstract

In this study we used human monoclonal antibody (Hu-mAb) L72 as an intratumoral injection of cutaneous metastasis of melanoma to study its anti-tumor effects in human patients. Hu-mAb L72 was developed by transforming peripheral blood lymphocytes from a melanoma patient in vitro with the Epstein-Barr virus, forming a human lymphoblastoid cell line that produces 2-5 micrograms of IgM per ml. This IgM Hu-mAb was shown to react specifically with ganglioside GD2 and have a strong cytotoxic effect on human melanoma cells in the presence of complement. Patients with cutaneous metastatic melanoma were given intralesional injections on a daily or weekly injection schedule. Regression was seen in all tumors except in those of two patients whose tumors were shown to have low antigenicity. Histopathological data showed tumor degeneration, fibrosis, free melanin, and some degree of lymphocyte or macrophage infiltration. One patient with melanoma satellitosis treated with Hu-mAb showed complete regression with no sign of recurrence 20 months after the initial treatment. With the exception of mild erythema, no side effects were observed in any patient.

Full text

PDF
8694

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando S., Chang N. C., Yu R. K. High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species. Anal Biochem. 1978 Sep;89(2):437–450. doi: 10.1016/0003-2697(78)90373-1. [DOI] [PubMed] [Google Scholar]
  2. Cahan L. D., Irie R. F., Singh R., Cassidenti A., Paulson J. C. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7629–7633. doi: 10.1073/pnas.79.24.7629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GORDON J., ROSE B., SEHON A. H. Detection of non-precipitating antibodies in sera of individuals allergic to ragweed pollen by an in vitro method. J Exp Med. 1958 Jul 1;108(1):37–51. doi: 10.1084/jem.108.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gomibuchi M., Saxton R. E., Lake R. R., Katano M., Irie R. F. Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodies. Int J Rad Appl Instrum B. 1986;13(1):13–19. doi: 10.1016/0883-2897(86)90246-1. [DOI] [PubMed] [Google Scholar]
  5. Irie R. F., Sze L. L., Saxton R. E. Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5666–5670. doi: 10.1073/pnas.79.18.5666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jerne N. K. Idiotypic networks and other preconceived ideas. Immunol Rev. 1984 Jun;79:5–24. doi: 10.1111/j.1600-065x.1984.tb00484.x. [DOI] [PubMed] [Google Scholar]
  7. Jerne N. K., Roland J., Cazenave P. A. Recurrent idiotopes and internal images. EMBO J. 1982;1(2):243–247. doi: 10.1002/j.1460-2075.1982.tb01154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jourdian G. W., Dean L., Roseman S. The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem. 1971 Jan 25;246(2):430–435. [PubMed] [Google Scholar]
  9. Katano M., Irie R. F. Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice. Immunol Lett. 1984;8(4):169–174. doi: 10.1016/0165-2478(84)90072-5. [DOI] [PubMed] [Google Scholar]
  10. Katano M., Jien M., Irie R. F. Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft. Eur J Cancer Clin Oncol. 1984 Aug;20(8):1053–1059. doi: 10.1016/0277-5379(84)90108-1. [DOI] [PubMed] [Google Scholar]
  11. Katano M., Saxton R. E., Irie R. F. Human monoclonal antibody to tumor-associated ganglioside GD2. J Clin Lab Immunol. 1984 Nov;15(3):119–126. [PubMed] [Google Scholar]
  12. Katano M., Saxton R. E., Tsuchida T., Irie R. F. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft. Jpn J Cancer Res. 1986 Jun;77(6):584–594. [PubMed] [Google Scholar]
  13. Tai T., Cahan L. D., Paulson J. C., Saxton R. E., Irie R. F. Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients. J Natl Cancer Inst. 1984 Sep;73(3):627–633. [PubMed] [Google Scholar]
  14. Tai T., Cahan L. D., Tsuchida T., Saxton R. E., Irie R. F., Morton D. L. Immunogenicity of melanoma-associated gangliosides in cancer patients. Int J Cancer. 1985 May 15;35(5):607–612. doi: 10.1002/ijc.2910350507. [DOI] [PubMed] [Google Scholar]
  15. Tai T., Paulson J. C., Cahan L. D., Irie R. F. Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sci U S A. 1983 Sep;80(17):5392–5396. doi: 10.1073/pnas.80.17.5392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Watanabe T., Pukel C. S., Takeyama H., Lloyd K. O., Shiku H., Li L. T., Travassos L. R., Oettgen H. F., Old L. J. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med. 1982 Dec 1;156(6):1884–1889. doi: 10.1084/jem.156.6.1884. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES